MAB Share Price Performance
zł8.15
-3.65 (-30.93%)
Price zł8.15
Share Pricen/a
Mabion S.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
MAB Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Mabion S.A. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -4.01
- -251.70%
- -576.71%
- 0.6%
About MAB
- Founded
- 2007
- Employees
- 210
- CEO
- WebsiteView website
Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial: end-to-end development, process development, analytics, and cell line development and banking services. The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.
